Intraoperative Dosing of Dexamethasone in Type II Diabetics Undergoing Bariatric Surgery

Doctoral Candidate Name: Natalie Gabhart
Program: Doctor of Nursing Practice
Defense Date and Time: December 8, 2023 – 10:00 AM
Defense Location: CHHS 436
Committee chair’s Name: Dr. Stephanie Woods
Committee Members: Dr. Katie Shue-McGuffin, Dr. Danielle Brown, Dr. Catherine Helms, Dr. Suzanne Boyd
Abstract:

Purpose: Identifying trends in the intraoperative dosing of dexamethasone in type II diabetic patients undergoing bariatric procedures at a community hospital to determine impact of the dose received on perioperative glycemic control.

Background: Dexamethasone is a corticosteroid and despite its many documented benefits when administered perioperatively to surgical patients, it is often withheld in the type II diabetic population out of concern for postoperative hyperglycemia.

Methods: Retrospective chart reviews of 36 type II diabetics receiving dexamethasone undergoing bariatric procedures was completed. Inclusion criteria: type II diabetics, procedures